EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $342,253 | -14.4% | 33,036 | -2.4% | 0.00% | -25.0% |
Q4 2022 | $399,627 | -30.0% | 33,838 | +24.4% | 0.00% | -20.0% |
Q3 2022 | $571,000 | -38.3% | 27,211 | -8.7% | 0.01% | -44.4% |
Q2 2022 | $925,000 | -56.6% | 29,805 | -42.6% | 0.01% | -60.9% |
Q1 2022 | $2,131,000 | -21.2% | 51,905 | -16.6% | 0.02% | -23.3% |
Q4 2021 | $2,706,000 | -17.9% | 62,260 | -5.4% | 0.03% | -6.2% |
Q3 2021 | $3,296,000 | -29.2% | 65,819 | -11.0% | 0.03% | -22.0% |
Q2 2021 | $4,656,000 | -49.6% | 73,919 | -25.7% | 0.04% | -54.4% |
Q1 2021 | $9,247,000 | +5.1% | 99,526 | +1.3% | 0.09% | -9.1% |
Q4 2020 | $8,802,000 | +21.5% | 98,239 | +40.1% | 0.10% | -7.5% |
Q3 2020 | $7,245,000 | +28.1% | 70,119 | -2.0% | 0.11% | +40.8% |
Q2 2020 | $5,656,000 | +5.1% | 71,518 | -30.5% | 0.08% | +81.0% |
Q3 2019 | $5,380,000 | +3.9% | 102,901 | -4.0% | 0.04% | +10.5% |
Q2 2019 | $5,177,000 | -17.1% | 107,161 | -13.3% | 0.04% | -13.6% |
Q1 2019 | $6,248,000 | -15.5% | 123,667 | -0.9% | 0.04% | -22.8% |
Q4 2018 | $7,396,000 | +17.2% | 124,763 | +30.2% | 0.06% | +39.0% |
Q3 2018 | $6,309,000 | +55.2% | 95,834 | +19.0% | 0.04% | +51.9% |
Q2 2018 | $4,066,000 | +2.5% | 80,540 | +6.9% | 0.03% | -15.6% |
Q1 2018 | $3,968,000 | +47.0% | 75,360 | +29.7% | 0.03% | +68.4% |
Q4 2017 | $2,700,000 | +26.4% | 58,094 | +10.0% | 0.02% | +26.7% |
Q3 2017 | $2,136,000 | +70.3% | 52,811 | +42.9% | 0.02% | +66.7% |
Q2 2017 | $1,254,000 | +23.4% | 36,967 | +5.6% | 0.01% | +28.6% |
Q1 2017 | $1,016,000 | -20.5% | 35,003 | -10.1% | 0.01% | -22.2% |
Q4 2016 | $1,278,000 | -21.4% | 38,918 | -24.5% | 0.01% | -30.8% |
Q3 2016 | $1,626,000 | -15.4% | 51,578 | -24.5% | 0.01% | -23.5% |
Q2 2016 | $1,921,000 | -7.8% | 68,308 | +19.2% | 0.02% | -22.7% |
Q1 2016 | $2,083,000 | +1.5% | 57,308 | +11.7% | 0.02% | +10.0% |
Q4 2015 | $2,053,000 | -88.1% | 51,300 | -15.5% | 0.02% | +11.1% |
Q3 2015 | $17,303,000 | +1280.9% | 60,732 | +59.7% | 0.02% | +63.6% |
Q2 2015 | $1,253,000 | +131.6% | 38,031 | +102.1% | 0.01% | +175.0% |
Q1 2015 | $541,000 | +10.2% | 18,815 | -13.9% | 0.00% | 0.0% |
Q2 2014 | $491,000 | -8.7% | 21,856 | +2.6% | 0.00% | -20.0% |
Q1 2014 | $538,000 | – | 21,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |